Federation Des Caisses Desjardins Du Quebec Kaleido Biosciences, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 14, 2024	SELL	$0.05 - $1.7 $146 - $4,981	-2,930 Closed	0 $0
Q1 2022 Aug 14, 2024	BUY	$1.3 - $2.7 $3,809 - $7,911	2,930 New	2,930 $4.84 Million
Q4 2021 Aug 30, 2024	BUY	$2.39 - $6.02 $2,390 - $6,020	1,000 Added 69.93%	2,430 $5.81 Million
Q3 2021 Aug 30, 2024	BUY	$5.36 - $7.99 $1,072 - $1,598	200 Added 16.26%	1,430 $7.81 Million
Q2 2021 Aug 30, 2024	BUY	$5.82 - $8.72 $7,158 - $10,725	1,230 New	1,230 $9.15 Million
Q1 2021 Aug 30, 2024	BUY	$7.2 - $16.82 $936 - $2,186	130 Added 18.57%	830 $6.72 Million
Q4 2020 Aug 30, 2024	BUY	$5.77 - $11.33 $4,038 - $7,931	700 New	700 $6.37 Million
Q1 2020 Aug 30, 2024	SELL	$3.62 - $9.49 $1,810 - $4,745	-500 Closed	0 $0
Q4 2019 Aug 30, 2024	BUY	$5.02 - $8.87 $2,510 - $4,435	500 New	500 $2.51 Million

Others Institutions Holding KLDO

# of Institutions

Shares Held

2.65K

Call Options Held

Put Options Held

View Full List

About Kaleido Biosciences, Inc.

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

More about KLDO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account